Login / Signup

[Low-dose naltrexone (LDN): consumption trend in Brazilian capitals and the Federal District, 2014-2020].

Michele Gabriela SchmidtIraci Lucenada Silva TorresDouglas Nunes StahnkeVera Maria Vieira Paniz
Published in: Ciencia & saude coletiva (2022)
The scope of this paper is an ecological study to determine the consumption of low-dose naltrexone (LDN) in the 26 Brazilian capitals and the Federal District and monitor the trend between the years 2014 to 2020. Data collection on the dispensation of manipulated naltrexone was done through the National Management System of Controlled Products, published in 2020, considering low-dose prescriptions of up to 5 mg. The calculation of the dispensation coefficients used the population estimates of the Brazilian Institute of Geography and Statistics. Descriptive statistical analysis and generalized Prais-Winsten regression analysis were used for the time series analysis. The trends observed were classified as increasing, stable, or decreasing, with a 95% confidence interval and 5% significance level. The results showed higher LDN consumption coefficients in the Mid-West, South and Southeast regions and lower coefficients in the North and Northeast. Increasing dispensation of LDN was observed in 55.6% of the capitals, being stationary in 44.4%, with no decreasing coefficients. Despite the limited evidence regarding LDN pharmacotherapy and its off-label prescription, the data show that prescription, dispensing, and consumption have been on the increase in Brazil, with emphasis on the central-south regions of the country.
Keyphrases
  • low dose
  • high dose
  • south africa
  • electronic health record
  • big data
  • climate change
  • alcohol use disorder
  • systematic review
  • smoking cessation
  • deep learning
  • data analysis
  • artificial intelligence